Enoxaparin Injections & IVF

Enoxaparin injections are often used as an adjunctive treatment during In Vitro Fertilization (IVF) to improve the chances of a successful pregnancy. As a fertility specialist in Chennai, I often encounter patients who have questions about Enoxaparin, its role in IVF, benefits, and potential side effects. This blog post aims to provide comprehensive information about Enoxaparin injections and their use in IVF treatment, specific to the context of fertility care in Chennai.

What Is Enoxaparin and How Does It Work in IVF?

Enoxaparin is a low molecular weight heparin (LMWH), a type of blood thinner. Unlike traditional heparin, Enoxaparin has a smaller molecular size, offering more predictable anticoagulant effects and a lower risk of heparin-induced thrombocytopenia (HIT). It exerts its anticoagulant effect mainly by inhibiting factor Xa rather than factor IIa. In the context of IVF, Enoxaparin is prescribed to address specific issues that can hinder implantation and early pregnancy. These issues include:

• Thrombophilia: Some women have inherited or acquired clotting disorders (thrombophilia) that increase the risk of blood clots in the placenta, potentially leading to implantation failure or miscarriage. Enoxaparin helps prevent these clots.
• Recurrent Pregnancy Loss: For women with a history of recurrent pregnancy loss, Enoxaparin may improve blood flow to the uterus and placenta, supporting a healthy pregnancy.
• Assisted Reproductive Technology (ART) Protocols: Some IVF protocols may increase the risk of blood clots due to hormonal stimulation. Enoxaparin can mitigate this risk.

The potential mechanism is that LMWH could exert its anticoagulant effect by inhibiting factor Xa, reducing the risk of insufficiency blood supply in the very early stage of pregnancy. LMWH is also supposed to play a role in manipulating blastocyst supposition, adhesion, and implantation, as well as trophoblast differentiation and invasion.

Who Needs Enoxaparin During IVF Treatment?

Not every woman undergoing IVF needs Enoxaparin injections. As a fertility specialist, I carefully assess each patient's medical history, risk factors, and specific circumstances to determine if Enoxaparin is appropriate. Enoxaparin may be considered in the following situations:

• Diagnosed Thrombophilia: Women with confirmed clotting disorders, such as Factor V Leiden, Prothrombin gene mutation, or Antiphospholipid Syndrome (APS).
• Recurrent Pregnancy Loss (RPL): Patients with a history of two or more unexplained miscarriages may benefit from Enoxaparin to improve placental blood flow.
• Repeated Implantation Failure (RIF): Women who have experienced multiple failed IVF cycles despite good quality embryos may be prescribed Enoxaparin to enhance implantation. A meta-analysis reported that there is no difference in implantation rate in women with ≥3 recurrent implantation failure when treated with LMWH.
• Certain Autoimmune Conditions: Patients with autoimmune diseases like Systemic Lupus Erythematosus (SLE) may have an increased risk of blood clots.
• Elevated Body Mass Index (BMI): Obese women are at higher risk of venous thromboembolism (VTE) and may require prophylactic Enoxaparin. NICE estimates that LMWH reduces VTE risk in medical and surgical patients by 60% and 70% respectively.

It's essential to note that recent research suggests that Enoxaparin may not provide a benefit for women who do not have an underlying blood clotting issue.

Enoxaparin Dosage, Administration, and Timing in IVF

The typical prophylactic dose of Enoxaparin is 40 mg administered subcutaneously (under the skin) once daily. However, the specific dosage and timing of Enoxaparin injections can vary depending on individual patient factors and the IVF protocol.

• Dosage: Common prophylactic dose is Enoxaparin 40 mg subcutaneously once daily. For thrombotic APS: Therapeutic-dose LMWH (enoxaparin 1 mg/kg subcutaneously every 12 hours). In some studies, enoxaparin (20 mg/d/s.c.) was started previous to conception and adapted to the fertility program.
• Administration: Enoxaparin is administered via subcutaneous injection, usually in the abdomen. Patients are typically taught how to self-administer the injections. Proper technique is crucial to minimise bruising and discomfort.
• Timing: The timing of Enoxaparin initiation varies. Some protocols start it around the time of egg retrieval or embryo transfer, while others may begin earlier, during ovarian stimulation. The duration of treatment also depends on individual circumstances, and it may continue throughout the first trimester or even the entire pregnancy.

As I advise my patients in Chennai, strict adherence to the prescribed dosage and timing is critical for optimal results and to minimise potential risks.

Enoxaparin Side Effects and Safety Considerations

While Enoxaparin is generally safe, it's essential to be aware of potential side effects and safety considerations:

• Common Side Effects: The most common side effects include bruising, pain, or redness at the injection site. These are usually mild and resolve on their own.
• Bleeding Risk: Enoxaparin thins the blood, increasing the risk of bleeding. Patients should report any unusual bleeding, such as nosebleeds, heavy menstrual bleeding, blood in the urine or stool, or prolonged bleeding from cuts.
• Allergic Reactions: Although rare, allergic reactions to Enoxaparin can occur. Symptoms may include rash, itching, swelling, or difficulty breathing. Seek immediate medical attention if you experience any of these symptoms.
• Heparin-Induced Thrombocytopenia (HIT): HIT is a rare but serious complication in which the body forms antibodies against heparin, leading to a decrease in platelet count and an increased risk of blood clots. Regular platelet monitoring is essential during Enoxaparin therapy.
• Osteoporosis: Long-term use of heparin products may increase the risk of osteoporosis. Discuss calcium and vitamin D supplementation with your doctor if you require prolonged Enoxaparin treatment.
• NICE estimates that LMWH reduces VTE risk in medical and surgical patients by 60% and 70% respectively, therefore it is reasonable to presume LMWH may reduce the risk of VTE in pregnancy and the puerperium. Enoxaparin is considered safe to be used during pregnancy and breastfeeding.

The following table summarizes the potential side effects of Enoxaparin:

Enoxaparin Injection in IVF Success Rates and Evidence

The impact of Enoxaparin on IVF success rates is a topic of ongoing research and debate. While some studies have shown potential benefits in specific patient populations, others have not found a significant difference.

• Women with Thrombophilia or RPL: Enoxaparin may improve IVF success rates in women with diagnosed thrombophilia or a history of recurrent pregnancy loss by improving uterine blood flow and reducing the risk of placental blood clots. One study found that enoxaparin use has shown promising, possibly advantageous results.
• Women without Thrombophilia: Recent research suggests that Enoxaparin may not offer a significant benefit to women without underlying clotting disorders. A 2025 single-blinded randomized clinical trial (n=80) found that enoxaparin (40 mg daily) in women with URPL and no thrombophilia did not improve live birth rates compared to routine pregnancy care (85% in both groups). Pregnancy complications were significantly higher in the enoxaparin group (38.2% vs. 5.7%; P=0.021). The study recommends against LMWH use in URPL patients without thrombophilia.
• Meta-Analyses: Meta-analyses and systematic reviews have yielded mixed results. A meta-analysis reported that there is no difference in implantation rate in women with ≥3 recurrent implantation failure when treated with LMWH.

As a fertility specialist, I carefully consider the available evidence and individual patient factors when deciding whether to prescribe Enoxaparin. It's important to have a thorough discussion with your doctor to weigh the potential benefits and risks in your specific situation.

Enoxaparin Cost in Chennai

The cost of Enoxaparin injections in Chennai can vary depending on the brand (e.g., Clexane), dosage, and pharmacy. A month's supply typically ranges from ₹2,000 to ₹5,000. Some insurance providers may cover the cost of Enoxaparin if it is prescribed for a medically necessary condition.

Here's an estimated cost breakdown:

It's advisable to check with local pharmacies in areas like Mylapore, Chetpet, and Kilpauk for the most up-to-date pricing.

When to Seek Professional Help

Enoxaparin injections can be a valuable tool in IVF treatment for specific patient populations. However, it's not a one-size-fits-all solution. As Dr. Rukkayal Fathima, I emphasize the importance of a thorough evaluation, individualized treatment plan, and careful monitoring to ensure the best possible outcome. For personalised guidance, book a consultation with Dr. Rukkayal Fathima.